( en | de | ru )

 

Disambiguierung von "Hasenclever, Dirk"

Autor der Publikation

KopierenLöschenDiese Publikation zur Ablage hinzufügen
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma

, , , , , , , , , , , , , , , , und . British journal of haematology, 144 (3): 317–331 (2009)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

Dirk Hasenclever

Hertha Hasenclever

Max Hasenclever

Christa Hasenclever

Jörg Hasenclever

 

Weitere Publikationen von Autoren mit dem selben Namen

Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF, , , , , , , , , und 3 andere Autor(en). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 12 (4): 471–477 (2001)Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence, , und . Antiviral therapy, 13 (2): 211–220 (2008)Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group, , , , , , , , , und . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12 (3): 580–586 (1994)Are endoscopic antireflux therapies cost-effective compared with laparoscopic fundoplication?, , , , , , und . Endoscopy, 37 (3): 217–222 (2005)The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis, , , , , , , , , und 1 andere Autor(en). Thrombosis and haemostasis, 99 (5): 925–929 (2008)Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL, , , , , , , , , und 3 andere Autor(en). Blood, 104 (3): 634–641 (2004)Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study, , , , , , , , , und 10 andere Autor(en). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 (23): 3680–3686 (2010)High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML), , , , , , , , und . Leukemia, 16 (1): 22–29 (2002)A novel view on stem cell development: analysing the shape of cellular genealogies, , , und . Cell proliferation, 42 (2): 248–263 (2009)Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks, und . Bone marrow transplantation, (1996)